5,120 results match your criteria: "Congestive Heart Failure Surgical Options"

Background: There are several high-risk treatment options for valve failure of a biological full root replacement. When tailoring the best treatment option for the patient, implantation of a rapid deployment valve (RDV) should be considered.

Case Presentation: Six patients presented with aortic regurgitation in a full root Freestyle bioprosthesis.

View Article and Find Full Text PDF

Acute Tracheal Obstruction Secondary to Cervical Liposarcoma Metastasis.

Thorac Cancer

December 2024

Provincial Higher Medical College, North Sichuan Medical College, Nanchong, Sichuan Province, China.

Tracheal obstruction can arise from multiple conditions, including chronic obstructive pulmonary disease, asthma, foreign bodies, tumors, and acute heart failure. We report a case of a 43-year-old man with cervical liposarcoma who, following surgical excision, chemotherapy, and radiation, presented with severe dyspnea and was admitted to our hospital. A CT scan detected an endotracheal mass causing significant obstruction, suspected to be malignant.

View Article and Find Full Text PDF

Research on rheumatic heart disease from 2013 to early 2024: a bibliometric analysis.

J Cardiothorac Surg

December 2024

Department of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.

Objectives: The aim of this bibliometric analysis was to highlight potential future areas for the practical application of research on rheumatic heart disease (RHD), considering past and current research efforts.

Methods: A systematic search was conducted in the WoSCC to find articles and reviews focused on RHD published between 2013 and 2024. Microsoft Excel 2019 was used to chart the annual productivity of research relevant to RHD, while ArcGIS (version 10.

View Article and Find Full Text PDF

Background: In STREAM-1 (Strategic Reperfusion Early After Myocardial Infarction), excess intracranial hemorrhage occurred in patients aged ≥75 years receiving full-dose tenecteplase as part of a pharmaco-invasive strategy, whereas no further intracranial hemorrhage occurred after halving the tenecteplase dose. In STREAM-2 (Second Strategic Reperfusion Early After Myocardial Infarction), half-dose tenecteplase was an effective and safe pharmaco-invasive strategy in older patients with ST-segment-elevation myocardial infarction presenting within <3 hours, compared with primary percutaneous coronary intervention (PCI). We prespecified evaluating the efficacy and safety of a half-dose versus full-dose pharmaco-invasive strategy and compared the half-dose pharmaco-invasive strategy to primary PCI in patients aged ≥75 years.

View Article and Find Full Text PDF

Background: Diagnosing cardiac sarcoidosis (CS) is challenging. Immunosuppressive therapies are less effective in end-stage disease, and often heart transplant (HT) is the only available option. We present a series of advanced CS cases, requiring HT, along with a review of the literature evidence in this field.

View Article and Find Full Text PDF

Implications of Preoperative C-Reactive Protein Levels in Heart Transplant Patients-A Single-Center Retrospective Study.

J Clin Med

December 2024

Department of Cell and Molecular Biology, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania.

: Heart transplant is the final therapeutic option for end-stage heart failure patients. It has been used with increasing success as a surgical procedure, greatly influenced by advances in diagnostic and prognostic tools. The aim of this paper was to study potential implications of C-reactive protein (CRP) in patients who underwent heart transplants.

View Article and Find Full Text PDF

Background: Bilateral cardiac sympathetic denervation (CSD) performed via video-assisted thoracoscopic (VAT) surgery shows potential in managing ventricular tachycardia (VT), thereby reducing arrhythmic burden. In this setting, the scarcity of studies addressing both perioperative and long-term outcomes creates a substantial gap in the optimal management of patients with multiple comorbidities and limited treatment options. This observational study aimed to assess the medical comorbidities, as well as the short- and long-term outcomes of patients who underwent CSD for VT refractory to catheter ablation and medical therapy at a referral tertiary teaching hospital.

View Article and Find Full Text PDF

Background: Obesity is associated with excessive adipocyte-derived aldosterone secretion, independent of the classical renin-angiotensin-aldosterone cascade, and mineralocorticoid receptor antagonists may be more effective in patients with heart failure (HF) and obesity.

Objectives: This study sought to examine the effects of the nonsteroidal mineralocorticoid receptor antagonist finerenone compared with placebo, according to body mass index (BMI) in FINEARTS-HF (FINerenone trial to investigate Efficacy and sAfety superioR to placebo in paTientS with Heart Failure).

Methods: A total of 6,001 patients with HF with NYHA functional class II, III, and IV, a left ventricular ejection fraction of ≥40%, evidence of structural heart disease, and elevated natriuretic peptide levels were randomized to finerenone or placebo.

View Article and Find Full Text PDF

Management of acute decompensated valvular heart disease.

Eur J Heart Fail

December 2024

Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany and DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock. Current evidence remains scarce and recommendations regarding the management of acute heart failure caused by VHD are lacking in most recent international guidelines.

View Article and Find Full Text PDF

Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry.

JACC Cardiovasc Interv

December 2024

Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany. Electronic address:

Article Synopsis
  • Atrial secondary tricuspid regurgitation (A-STR) is a subtype of secondary tricuspid regurgitation (STR) that is often treated with transcatheter tricuspid valve edge-to-edge repair (T-TEER), showing distinct patient characteristics and treatment outcomes.
  • A study involving 641 patients revealed that 31% had A-STR, which was linked to better heart function, a higher presence of atrial fibrillation, and more effective TR reduction post-procedure compared to nonatrial STR patients.
  • A-STR patients experienced improved survival rates and lower symptomatic burdens after treatment; only 38% remained symptomatic (NYHA class ≥III) after 2 years, compared to 46
View Article and Find Full Text PDF

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy.

JACC Cardiovasc Interv

December 2024

University of Virginia, Charlottesville, Virginia, USA. Electronic address: https://twitter.com/psorajja.

Article Synopsis
  • Untreated severe tricuspid regurgitation (TR) is linked to poor health outcomes, making effective treatment essential.
  • The study evaluated the 1-year results of transcatheter edge-to-edge repair (TEER) using the TriClip system in patients with complex tricuspid valve issues, finding significant improvements in patient survival and quality of life.
  • Results showed that 81% of patients experienced a reduction in TR to moderate or less after one year, with no major adverse effects noted in the first 30 days post-procedure.
View Article and Find Full Text PDF

Aims: Tricuspid regurgitation affects 7% of the population, with moderate-to-severe tricuspid regurgitation contributing to up to 12% of heart failure-related hospitalizations. Traditional treatments have several limitations, prompting the exploration of innovative interventions. Our study aims to investigate the efficacy and clinical outcomes following transcatheter edge-to-edge repair (TEER) in patients with severe, symptomatic tricuspid regurgitation through a 1-year follow-up.

View Article and Find Full Text PDF

Aims: Catheter-based radiofrequency renal denervation (RF RDN) is an interventional treatment for uncontrolled hypertension. This analysis explored the therapy's lifetime cost-effectiveness in a Canadian healthcare setting.

Materials And Methods: A decision-analytic Markov model was used to project health events, costs, and quality-adjusted life years over a lifetime horizon.

View Article and Find Full Text PDF

Study Design: Retrospective cohort study.

Summary Of Background Data: The optimal surgical approach for multilevel cervical stenosis in elderly patients is controversial because of the risk of life-threatening complication.

Objective: To compare life-threatening early complication rates between ≥3 levels anterior and posterior cervical surgery in elderly patients.

View Article and Find Full Text PDF

[Recent Topics on Heart Failure].

No Shinkei Geka

November 2024

Department of Cardiology, Nagoya City University, Graduate School of Medical Sciences.

Article Synopsis
  • Japan is facing a heart failure pandemic due to its aging population, leading to increased cases that seriously impact life expectancy.
  • Early diagnosis and tailored treatment strategies, based on distinct stages of heart failure, are becoming crucial for effective management.
  • Recent advancements in both pharmacological and non-pharmacological treatments have improved patient outcomes, emphasizing the need for multidisciplinary teams to provide comprehensive care.
View Article and Find Full Text PDF
Article Synopsis
  • * The condition significantly impacts life expectancy and healthcare costs, as it has a high 5-year mortality rate of 60-70%.
  • * Advances in treatment options have emerged, including new medications and surgical solutions like heart transplantation and left ventricular assist devices, while further research is needed on diagnostics and therapies for heart failure.
View Article and Find Full Text PDF
Article Synopsis
  • Tricuspid valve pathology is common and presents challenges for mechanical tricuspid valve replacement, particularly when implanting a permanent pacemaker due to risks like valve damage and lead fractures.
  • Epicardial leads, while an option, are not ideal for patients with past thoracotomies due to surgical requirements.
  • This case report showcases successful left ventricular (LV) pacing through the coronary sinus in a 30-year-old woman, proving it to be a safe and effective alternative method for pacemaker implantation without additional invasive procedures.
View Article and Find Full Text PDF
Article Synopsis
  • Wearable accelerometers provide a way to continuously monitor physical activity in patients with heart failure, which could be useful for assessing treatment effects.
  • In the DETERMINE trials, a subgroup of patients wore accelerometers at different points while also completing questionnaires and walking tests to evaluate their functional status.
  • Results showed that lower activity levels were associated with worse health scores and measures, but overall, the relationships between accelerometer data and health assessments were generally weak, suggesting accelerometers could offer additional insights beyond traditional methods.
View Article and Find Full Text PDF

Kill two birds with one stone: Hapatologist's approach to metabolic dysfunction-associated steatotic liver disease and heart failure.

World J Cardiol

November 2024

Division of Gastroenterology and Hepatology, Department of Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, United States.

Article Synopsis
  • * The article reviews the common pathophysiology of HF and MASLD and assesses the available treatments, emphasizing guideline-directed medication therapy (GDMT) which includes ACE inhibitors, ARBs, beta-blockers, and other medications.
  • * Recent studies suggest that some GDMT medications beneficially impact both HF and MASLD, but further research is needed to validate the effectiveness of other treatments and novel therapies for these conditions.
View Article and Find Full Text PDF

The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes.

Medicina (Kaunas)

November 2024

Department of Cell and Molecular Biology, George Emil Palade University of Medicine Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.

Article Synopsis
  • - Cardiac transplantation improves survival for patients with severe heart failure, but managing postoperative complications is difficult for doctors! - A study analyzed 50 patients who had heart transplants, focusing on how their pre-surgery heart failure treatments impacted complications after the surgery! - Results showed that Carvedilol was linked to lower 2-month mortality and helped prevent acute kidney injury, while Ramipril and Spironolactone were associated with shorter hospital stays and fewer complications!
View Article and Find Full Text PDF

Transcatheter Interventions in Adults With Fontan Palliation.

Circ Cardiovasc Interv

December 2024

Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre (R.A.-G., M.O., L.B., E.H.), University Health Network, ON, Canada.

Article Synopsis
View Article and Find Full Text PDF
Article Synopsis
  • Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is a new standard treatment for patients with degenerated bioprosthetic valves, but it can lead to patient-prosthesis mismatch affecting survival.
  • This study analyzed the safety and effectiveness of bioprosthetic valve fractures in 25 patients who underwent ViV-TAVI between 2015 and 2022, using echocardiograms to evaluate valve function before and after the procedure.
  • Results showed significant reductions in both peak and mean transvalvular gradients after fracturing, indicating it is a potential solution for improving outcomes in patients with high gradients or mismatch concerns.
View Article and Find Full Text PDF
Article Synopsis
  • Cyanotic congenital heart diseases are serious conditions in newborns, with a rare form involving the direct connection between the right pulmonary artery and left atrium, needing prompt correction to prevent heart failure.
  • Two patients, aged 2 and 13, presented with central cyanosis and difficulty breathing, leading to a diagnosis of abnormal blood flow via imaging techniques.
  • Treatment has evolved from surgical methods to less invasive percutaneous techniques, emphasizing the importance of early diagnosis and appropriate intervention based on the unique characteristics of the congenital anomaly.*
View Article and Find Full Text PDF
Article Synopsis
  • * Advanced techniques such as adeno-associated viral vectors and CRISPR-Cas9 are proving to be efficient for gene delivery and repairing genetic issues in humans.
  • * The statement reviews various gene therapy approaches for heart failure and its causes, discusses their clinical applications, and highlights safety concerns and regulatory challenges for future development.
View Article and Find Full Text PDF